AUSSENDER



Marinomed Biotech AG
Ansprechpartner: Pascal Schmidt, CFO
Tel.: +43 2262 90300
E-Mail: pascal.schmidt@marinomed.com
Pressefach (143)

Rechtsgrundlage

Alle
Insiderinformationen
Unternehmensmitteilungen
Finanzberichte
Stimmrechtsmitteilungen
HV-Bekanntmachungen
Sonstige

Schlagwörter

Gesamtzahl der Stimmrechte
DE EN
26.04.2021 - 12:30 | Marinomed Biotech AG
Yearly financial report according to article 124 BörseG
25.03.2021 - 07:45 | Marinomed Biotech AG
Marinomed Biotech AG enrolls first patient in clinical study of inhaled Carragelose to treat COVID-19 infections
11.03.2021 - 07:45 | Marinomed Biotech AG
First Patients in Phase II Clinical Trial of Tacrosolv to Treat Allergic Rhinoconjunctivitis (Hay Fever)
26.02.2021 - 10:00 | Marinomed Biotech AG
Marinomed Biotech AG Leads BCG's Gender Diversity Index Austria 2020
24.02.2021 - 07:45 | Marinomed Biotech AG
Positive clinical data for Carragelose lozenges against respiratory viruses including SARS-CoV-2
19.02.2021 - 14:05 | Marinomed Biotech AG
Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in prevention of COVID-19
18.02.2021 - 07:45 | Marinomed Biotech AG
Marinomed Biotech AG publishes new supporting data on the in vitro efficacy of Carragelose® against SARS-CoV-2
29.01.2021 - 07:45 | Marinomed Biotech AG
Marinomed Biotech AG announces preliminary revenues and confirms outlook for 2020
16.12.2020 - 07:45 | Marinomed Biotech AG
EU-wide patent protection for proprietary Marinosolv® platform
30.11.2020 - 07:30 | Marinomed Biotech AG
UK-based SARS-CoV-2 prophylactic trial with health care professionals
26.11.2020 - 07:45 | Marinomed Biotech AG
Marinomed Biotech reports record sales in the first nine months of 2020 and a positive outlook
20.11.2020 - 15:00 | Marinomed Biotech AG
Marinomed plans clinical trial with Carragelose nasal spray to investigate prevention of COVID-19 infection
30.10.2020 - 09:00 | Marinomed Biotech AG
Marinomed announces change to supervisory board
08.10.2020 - 09:00 | Marinomed Biotech AG
Marinomed develops first medicinal product for the treatment of autoimmune gastritis
08.09.2020 - 09:00 | Marinomed Biotech AG
Marinomed applies for drug approval for new decongestant nasal spray in Europe
|
99.115 Abonnenten
|
232.386 Meldungen
|
94.046 Pressefotos
|
Folgen Sie uns auf Twitter
|
Persönlicher Kontakt